Patents or patients: who loses?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 25203034.
- Also identified by DOI 10.1038/nbt.3005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The unprecedented weakening of patent rights in the United States undermines necessary incentives for the discovery and development of innovative medicines.
Medical subject headings
- Patents as Topic
- Patient Rights